Tuesday, January 19, 2021
Khmer Daily Cambodia News
26 °c
Phnom Penh
  • LATEST
  • CAMBODIA
  • ASIA
  • WORLD
  • BUSINESS
  • ENTERTAINMENT
  • LIFESTYLE
  • TECHNOLOGY
No Result
View All Result
  • LATEST
  • CAMBODIA
  • ASIA
  • WORLD
  • BUSINESS
  • ENTERTAINMENT
  • LIFESTYLE
  • TECHNOLOGY
No Result
View All Result
Khmer Daily Cambodia News
No Result
View All Result
Home ASIA India

India’s first Covid-19 vaccine candidate approved for human trials

Reuters by Reuters
June 30, 2020
in ASIA, India
0
India’s first Covid-19 vaccine candidate approved for human trials
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

BANGALORE – Bharat Biotech’s Covid-19 vaccine has been approved for human trials, making it India’s first domestic candidate to get the green light from the government’s drug regulator as cases surge in a country with more than 1.3 billion people.

The Drug Controller General of India has approved the company’s application to conduct a Phase I and II clinical trial of Covaxin, which was developed along with the Indian Council of Medical Research’s National Institute of Virology, the company said in a statement on Monday (June 29).

Human clinical trials are scheduled to start across the country in July for the vaccine, which was developed and manufactured in Bharat Biotech’s facility at Genome Valley in Hyderabad, India.

India, which lags only the United States, Brazil and Russia in total cases, reported close to 20,000 new infections on Monday, according to data from the country’s federal Health Ministry.

More than 16,000 people have died from the disease since the first case in India in January – low when compared to countries with similar numbers of cases. But experts fear hospitals in the densely populated nation will be unable to cope with a steep rise in cases.

No vaccine has yet been approved for commercial use against the illness caused by the new coronavirus, but over a dozen vaccines from more than a 100 candidates globally are being tested in humans.

China’s military received the approval to use a Covid-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some efficacy, the company said on Monday.

For the latest updates on the coronavirus, visit here.

This article was first published in Asia One . All contents and images are copyright to their respective owners and sources.

Tags: #coronavirus#COVID-19#india#vaccine
Previous Post

Reddit bans ‘The_Donald’ forum amid broad social media crackdown

Next Post

India bans 59 mostly Chinese apps, including TikTok and WeChat, amid border crisis

Next Post
India bans 59 mostly Chinese apps, including TikTok and WeChat, amid border crisis

India bans 59 mostly Chinese apps, including TikTok and WeChat, amid border crisis

Khmer Daily Latest News

China possibly committed ‘genocide’ against Xinjiang Uighurs, says US commission

China possibly committed ‘genocide’ against Xinjiang Uighurs, says US commission

January 19, 2021
‘Robust’ new Cambodia cassava policy aims to diversify farming and boost exports

‘Robust’ new Cambodia cassava policy aims to diversify farming and boost exports

January 19, 2021
Prince Bank: Multiple awards pave the way for an aspiring industry leader

Prince Bank: Multiple awards pave the way for an aspiring industry leader

January 19, 2021

© 2020 By Khmer Daily News

No Result
View All Result
  • Home
  • Latest
  • Cambodia
  • ASIA
  • World
  • Business
  • Tech

© 2020 Khmer Daily

error: Content is protected !!